M&A Deal Summary

Illumina Acquires GRAIL

On September 21, 2020, Illumina acquired life science company GRAIL for 8.0B USD

Acquisition Highlights
  • This is Illumina’s 6th transaction in the Life Science sector.
  • This is Illumina’s largest (disclosed) transaction.
  • This is Illumina’s 12th transaction in the United States.
  • This is Illumina’s 8th transaction in California.

M&A Deal Summary
Date 2020-09-21
Target GRAIL
Sector Life Science
Buyer(s) Illumina
Deal Type Add-on Acquisition
Deal Value 8.0B USD
Advisor(s) Morgan Stanley (Financial)
Latham & Watkins (Legal)

Target

GRAIL

Menlo Park, California, United States
website
GRAIL, Inc. is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on saving lives and improving health by pioneering new technologies for early cancer detection. GRAIL was established in 2016 and is based in Menlo Park, California.

Search 193,381 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Illumina

San Diego, California, United States

website

Category Company
Founded 1998
Sector Life Science
Employees11,500
Revenue 4.6B USD (2022)
DESCRIPTION
Entrance to Illumina's corporate headquarters in San Diego, California.
Entrance to Illumina's corporate headquarters in San Diego, California.

Illumina is a developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. Illumina provides innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA, and protein. The Company's customers include genomic research centers, academic institutions, government laboratories, hospitals, and reference laboratories as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic, and consumer genomics companies. Illumina was formed in 1998 and is based in San Diego, California.

DEAL STATS #
Overall 15 of 28
Sector (Life Science) 6 of 17
Type (Add-on Acquisition) 13 of 13
State (California) 8 of 11
Country (United States) 12 of 19
Year (2020) 2 of 2
Size (of disclosed) 1 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-06-17 BlueBee Holding BV

Rijswijk, Netherlands

BlueBee Holding BV is a cloud-based software company that provides genomics analysis solutions for research and clinical customers. BlueBee Holding is based in Rijswijk, Netherlands.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-01-06 Artemis Health

Salt Lake City, Utah, United States

Artemis Health is a provider of benefits data analytics and healthcare analytics to self-insured employers, employee benefits consultants, and benefits brokers. Artemis Health was founded in 2002 and is based in Salt Lake City, Utah.

Sell -
Mergr

Product

Company

Legal